Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (466)
Filter
351 - 360 of 678 results
  • Abstract
    Correlation of Odorant Structures with the Activity Patternsin the Rat Olfactory Bulb by Functional MRI.
    It is believed that the olfactory bulb (OB) codes the olfactory information from the periphery into a spatial activity pattern in the glomerular layer. Here we used high-resolution fMRI to examine how the structural features of odorants are represented spatially in the entire rat OB. The whole OB mapping results showed that the areas activated by the three structurally related odorants, iso-amyl acetate, ethyl acetate, and benzyl acetate distributed broadly across the entire OB. Many of the activated regions are shared by all three odorants. The patterns are more similar between the two aliphatic acetates than between the aliphatic and aromatic acetates. Statistical analysis showed that the similarity between the patterns of iso-amyl acetate in different exposures is significantly higher than between the patterns of iso-amyl acetate and ethyl acetate. One major cluster, covering nearly 60 glomeruli (thresholded at p < 0.01) at the latero-ventral region in the anterior end of the OB, was activated by the al...
    Nov 13, 2001
  • Abstract
    Screening and characterizing atypical and typical antipsychotics with magnetic resonance imaging and 3D computational analyses.
    Functional MRI in conscious animals provides a new opportunity in drug discovery to identify patterns of brain activity characteristic of different classes of psychotropic molecules. To this end, rats were tested with functionally different classes of drugs used to treat schizophrenia - atypical (clozapine, respiridone) and typical (chlorpromazine, haloperidol) antipsychotics. Rats showed a dose-dependent (change in brain activity dominated by negative BOLD signal) within 10-15 min of iv injection of drug. Since the efficacy of these drugs is related, in part, to their affinity for dopamine receptors, animals were challenged with an ICV injection of apomorphine following neuroleptic treatment. While several areas of the brain were activated by apomorphine administration alone, the most robust increase in BOLD signal intensity occurred in the prefrontal cortex. The typical antipsychotics, haloperidol and chlorpromazine blocked the action of apomorphine in the prefrontal cortex, while respiradol and clozapin...
    Oct 27, 2004
  • Abstract
    Observation of neural substrates involved in pain perception and analgesia by functional magnetic resonance imaging.
    Objectives: The purpose of the present study is to investigate the cortical changes in pain perception when applying different kind of conditioning sensory stimuli, namely acupuncture (Meridian) and acupuncture-like (Sham) stimuli and to show that these stimuli are essentially those of the stress-inducing stimuli and the results are the consequence of the HPA axis reflexes. Methods: Brain activation was observed with functional magnetic resonance imaging (fMRI) using a set of thermal stimuli as pain stimulus which induced by immersing the index finger into a hot water bath, approximately 51~52°C for 30 seconds. The experiment is performed by applying the pain following Meridian acupuncture and Sham acupuncture which applying needling to the traditionally known acupuncture points and points nearby but not those. These stimuli were manually twirling or rotating of a needle with approximately 1 Hz for a period of 30 seconds and rest period of 30 seconds with repetition of 5 times. Results: The results were co...
    Oct 27, 2004
  • Abstract
    Cocaine suppresses reward circuitry in lactating dams: Evidence from functional MRI and 3D computational analyses.
    Pups reinforcing properties are so robust that they compete with self-administration of cocaine (Hecht et al., Dev Psychobiol 35:136,1999). Indeed, postpartum dams bar press for pups in an operant response paradigm (Lee et al., Behav Brain Res 108:215, 2000). The present studies use fMRI and 3D computational analyses to compare pup-induced vs cocaine-induced changes in brain activity in lactating dams. Mothers were imaged for postnatal days 4 – 8 in response to pups (n=6) or ICV cocaine (20ug/10 ul) (n=6). A third group (n=6), imaged virgin females in response to ICV cocaine. A multi-slice fast spin echo sequence acquired twelve 1.2mm slices in 6s. All imaging consisted of 3 min (30 rep.) of control followed by 5 min (50 rep.) of stimulus. A 4.7T/40cm horiz. magnet was used. The results for n subjects in each group were presented individually and as group composites. The analysis involved three major steps registration, segmentation and statistical analysis. Subjects were registered to a fully segmented 3D...
    Oct 26, 2004
  • Abstract
    Human bold functional MRI at 4 and 7 tesla: evaluation of microvascular versus macrovascular contribution.
    It has been shown that the blood oxygenation level dependent (BOLD) functional MRI signal at magnetic field strengths of ≤ 1.5T arises predominantly from large vessels, which can be quite distant from the sites of neuronal activity. To improve the spatial localization to the active tissues/capillaries, the use of high field magnets has been proposed. To test this hypothesis, we evaluated the microvascular versus the macrovascular contribution to the BOLD response at high fields (4 and 7T) following visual stimulation in humans. Diffusion-weighted BOLD fMRI was used to selectively attenuate the fast-moving (large-vessel) fMRI signals. Two acquisition schemes were used: a gradient-echo scheme which is sensitive to both large- and small-vessel BOLD effects and a spin-echo scheme which should mitigate large-vessel BOLD effects. A comparison was made between the two sets of results. Diffusion-weighted BOLD fMRI was performed on 24 normal humans with graded flow-crushing gradients (4-7 b values). The visual stim...
    Nov 7, 2000
  • Abstract
    MRI studies of corpus callosum and hippocampus atrophy as independent markers of structural disease progression.
    Postmortem studies indicate a temporal sequence of primary allocortical and secondary neocortical degeneration during Alzheimer disease (AD) progression. Hippocampus (HC) atrophy correlates with allocortical neuronal degeneration and atrophy of the corpus callosum (CC) reflects loss of intracortical projecting pyramidal neurons in neocortex. First, we wanted to determine the temporal sequence and rate of degeneration of HC and CC in AD. Second, to answer the question, whether rates of atrophy were correlated with rates of cognitive decline and third, whether both markers could be proposed as potential morphological parameters for mapping drug effects on brain structure in longitudinally studied AD patients and healthy control subjects. MRI-derived measures of CC and HC were compared between 27 clinically diagnosed AD patients and 28 age- and gender-matched healthy control subjects. Rates of CC and HC atrophy were determined in 21 AD patients and 10 control subjects studied longitudinally. We found mean rel...
    Nov 5, 2000
  • Abstract
    MRI safety test at 1.5-tesla of a deep brain stimulation lead and trajectory guide.
    Stereotactic placement of deep brain stimulation (DBS) leads for the treatment of movement disorders has traditionally been guided by microrecording and macrostimulation in awake patients, with subsequent confirmation by MRI after the lead’s stylet has been removed. When placement errors occur, the surgery must be repeated and the lead replaced. Visual guidance by concurrent MRI would improve placement accuracy and reduce the need for repeated surgeries. An MRI-compatible trajectory guidance system (IGN) has been developed to fix DBS leads in place without removing the stylet, and allow remote adjustment of the lead position as needed. In preparation for clinical applications, we performed safety tests of this device in a 1.5-Tesla Siemens Sonata MR system. We evaluated local temperature changes using clinically relevant and ¨worst-case¨ MRI sequences in a semi-solid, gel-filled phantom. The lead tip (Medtronic), with stylet in place, was immersed into the phantom using the trajectory guide and remote intr...
    Nov 12, 2003
  • Abstract
    Functional MRI mapping of dopamine receptor-mediated neuronal activity in basal ganglia of parkinsonian monkeys.
    Previously, we have demonstrated that fMRI can be used to map age-associated changes in nigrostriatal system with dopaminergic stimulation in normal rhesus monkeys (NeuroImage 14: 1159-1167, 2001). In the present study, fMRI was used to map dopamine (DA) receptor-mediated blood oxygen level dependent (BOLD) changes indicative of neuronal activity in the basal ganglia of hemiparkinsonian rhesus monkeys. Unilateral infusion of MPTP via the right carotid artery was used to induce unilateral parkinsonian features in 12 monkeys; 3 age-matched normal monkeys served as controls. Apomorphine (APO, 0.1mg/kg s.c.), a mixed dopamine D1/D2 receptor agonist, evoked strong activation in the MPTP-lesioned caudate nucleus, putamen, globus pallidus (GP) and substantia nigra (SN) with little change detected on the intact side of these structures. The activation on the lesioned side persisted in the GP until administration 15 min later of the D1 receptor antagonist (SCH-23390, 0.1mg/kg i.m.). APO-induced activation was rever...
    Nov 12, 2003
  • Abstract
    in vitro study of MRI-related heating of deep brain stimulation electrodes at 1.5-tesla.
    Deep brain stimulation (DBS) is used increasingly in the field of movement disorders. The implanted electrodes create not only a priori risk to patient safety during MR imaging, but also a unique opportunity in the collection of functional MRI (fMRI) data conditioned by direct neural stimulation. We performed safety tests of commercially available bilateral neurostimulation systems (Soletra® 7482, Medtronic), extensions, and leads in a clinical 1.5 T MR system (Siemens, Germany) across a range of MR acquisitions of typical and worst case scenarios. The primary safety risk arises from RF induction of current through the electrode leads. It depends on the RF energy deposited during specific imaging sequences, on physical properties of the electrodes, and on the low impedance and/or resonant paths within the lead geometry. In vitro testing was performed using a phantom filled with a semisolid gel simulating the thermal convection and dielectric properties of human tissues. Each DBS electrode was positioned wi...
    Nov 12, 2003
  • Abstract
    Magnetic resonance imaging demonstrates differential atrophy of pontine base and tegmentum in machado-joseph disease.
    The pons is one of the brain areas demonstrating selective degeneration in Machado-Joseph disease (MJD), which is caused by the expansion of a polyglutamine stretch in the protein called ataxin-3. Although the resultant pontine atrophy is readily recognized by magnetic resonance imaging (MRI), the features and natural process of atrophy is not fully understood. To characterize these, we analyzed the midsagittal images of pons obtained by MRI. We found a difference in atrophy between the pontine base and tegmentum. The reduced size of the pontine tegmentum was prominent early after the onset of clinical symptoms. No overlap was seen in the range of the area of pontine tegmentum between MJD and controls. The quotient of atrophy of the pontine tegmentum divided by age correlated well with the CAG repeat number. In contrast, the area of the pontine base correlated negatively with disease duration. Particularly, the size of pontine base appeared to remain in the range of controls for a relatively long time afte...
    Nov 9, 2003
  • Previous
  • 34
  • 35
  • 36
  • 37
  • 38
  • Next

Featured

  • Congratulations to the 2026 FENS Forum Award winners!
  • 2026 Peter Seeburg Integrative Neuroscience Prize Awarded to Amy Arnsten
  • Upcoming Webinar: Positive Choice Bias and Resilience
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience